NCT00911196View on ClinicalTrials.gov

Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

Retrospective analysis of already archived samples

Analysis using RNA extracted from tissue samples already archived; Analysis by Fluorescent in situ hybridization (FISH) using tissue samples already archived.

Trial Locations (3)

100

GSK Investigational Site, Taipei

10700

GSK Investigational Site, Bangkok

50200

GSK Investigational Site, Chiang Mai

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY